Figure 2
From: Overexpression of the NEK9–EG5 axis is a novel metastatic marker in pathologic stage T3 colon cancer
Kaplan–Meier survival curves for overall survival (OS) according to the expression of NEK9, EG5 or acetyl-α-tubulin. (a) NEK9 expression in the whole cohort (n = 136). (b) NEK9 expression in the M0 patient subgroup (stage III; n = 87). (c) EG5 expression in the whole cohort. (d) Acetyl-α-tubulin expression in the whole cohort. OS differences were observed between the low- and high-expression cases for these proteins, with a more distinct difference for NEK9. M0, patients with no evidence of metastasis.
